InsiderTrades

Form 4 for AXSM Axsome Therapeutics, Inc.

Accepted 2025-06-18 00:00:00 ET · period of report 2025-06-16 · accession 0000950170-25-088105 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2025-06-18 2025-06-16+ AXSM Murdock Hunter R. GC M - OptEx $29.91 +22.5K 7,500 New +$673.0K
DMT 2025-06-18 2025-06-16+ AXSM Murdock Hunter R. GC S - Sale+OE $101.19 -22.5K 0 -100% -$2.28M
DMT 2025-06-18 2025-06-16+ AXSM Murdock Hunter R. GC M - OptEx $0.00 -22.5K 44.9K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-16 M A 7,500 $29.91 7,500 D — —
2 Common Common Stock 2025-06-16 S D 7,500 $102.42 0 D — — (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $101.01 and $104.09
3 Common Common Stock 2025-06-18 S D 7,500 $100.90 0 D — — (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.96.
4 Common Common Stock 2025-06-17 S D 7,500 $100.26 0 D — — (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.53.
5 Common Common Stock 2025-06-18 M A 7,500 $29.91 7,500 D — —
6 Common Common Stock 2025-06-17 M A 7,500 $29.91 7,500 D — —
7 Derivative Stock Option (Right to Buy) 2025-06-18 M D 7,500 $0.00 29,883 D $29.91 · 2023-03-04 to 2032-03-04 7,500 Common Stock
8 Derivative Stock Option (Right to Buy) 2025-06-17 M D 7,500 $0.00 37,383 D $29.91 · 2023-03-04 to 2032-03-04 7,500 Common Stock
9 Derivative Stock Option (Right to Buy) 2025-06-16 M D 7,500 $0.00 44,883 D $29.91 · 2023-03-04 to 2032-03-04 7,500 Common Stock